Ghost Tree Capital »

Annexon shares owned by Ghost Tree Capital

Quarter-by-quarter ownership of Annexon (ANNX) shares owned by Ghost Tree Capital from 13F filings

Historical chart of Ghost Tree Capital investment in Annexon

Tip: Access up to 7 years of quarterly data

All positions including Annexon held by Ghost Tree Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Annexon by Ghost Tree Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $2.6M 525k 4.90

More positions owned by Ghost Tree Capital

Alnylam Pharmaceuticals (ALNY)
Insmed Com Par $.01 (INSM)
Biohaven (BHVN)
Moonlake Immunotherapeutics Class A Ord (MLTX)
Soleno Therapeutics (SLNO)
Axsome Therapeutics (AXSM)
Ascendis Pharma A/s Sponsored Adr (ASND)
Vaxcyte (PCVX)
Crinetics Pharmaceuticals In (CRNX)
Roivant Sciences SHS (ROIV)
Perspective Therapeutics Com New
Tg Therapeutics (TGTX)
Sarepta Therapeutics (SRPT)
Cg Oncology (CGON)
Corbus Pharmaceuticals Hldgs Com New (CRBP)

View all positions for Ghost Tree Capital

Top funds holding Annexon

FMR
Bain Capital Life Sciences Investors
Satter Management
BVF
BlackRock
Redmile Group
Point72 Asset Management
Bellevue Group
Logos Global Management
Vanguard Group
Adage Capital Partners GP
Woodline Partners
GMT Capital Corp
Candriam Luxembourg S.C.A.
Geode Capital Management

View all funds holding Annexon